Records show BMC paid lobbying firm Rosemont Associates to convince state legislative budget committees to support an $11 million earmark to ease the sale of HUMC, according to the report. The owners of BMC currently want to buy HUMC for $65 million and convert it to a for-profit hospital. The $11 million in side funds would pay off the interest on HUMC’s bonds.
The BMC ownership group has also made numerous political contributions to New Jersey’s Democratic lawmakers, totaling more than $100,000 since 2008, the report said.
Related Articles on Healthcare Lobbying:
Health Lobbyists Flood Supercommittee
Survey: Most Physicians Say AMA Doesn’t Represent Their Views
Federation of American Hospitals Cuts 2Q Lobbying Expenses by 14%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
